Cited by

• Influence of nimodipine and nifedipine on intrapulmonary shunting--a comparison to other vasoactive drugs.

  Boldt J, Von Bormann B, Kling D, Ratthey K, Hempelmann G. Boldt J, et al. Intensive Care Med. 1987;13(1):52-6. doi: 10.1007/BF00263558. Intensive Care Med. 1987. Retraction in: Intensive Care Med. 2023 Aug;49(8):1043. doi: 10.1007/s00134-023-07124-6. PMID: 3104433 Retracted. Clinical Trial.
• Effect of diltiazem on hypoxic pulmonary vasoconstriction in dogs.

  Okutomi T, Wakabayashi C, Ikeda K. Okutomi T, et al. J Anesth. 1989 Sep 1;3(2):138-44. doi: 10.1007/s0054090030138. J Anesth. 1989. PMID: 15236029
• CT Emphysema Subtypes and Cardiac Hemodynamics Estimated on MRI: The Multi-Ethnic Study of Atherosclerosis COPD Study.

  Hermann EA, Yang JX, Angelini E, Balte P, Bluemke DA, Carr J, Derlin K, Gomes AS, Habibi M, Hoffman EA, Johns C, Kawut SM, Kiely DG, Laine A, Lima JAC, Prince MR, Smith B, Vogel-Claussen J, Watson K, Wild JM, Swift AJ, Barr RG. Hermann EA, et al. Chest. 2025 Aug;168(2):364-378. doi: 10.1016/j.chest.2025.03.009. Epub 2025 Mar 27. Chest. 2025. PMID: 40157599
• Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.

  Opie LH. Opie LH. Cardiovasc Drugs Ther. 1988 Mar;1(6):625-56. doi: 10.1007/BF02125750. Cardiovasc Drugs Ther. 1988. PMID: 3154329 Review.
• Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

  Sorkin EM, Clissold SP, Brogden RN. Sorkin EM, et al. Drugs. 1985 Sep;30(3):182-274. doi: 10.2165/00003495-198530030-00002. Drugs. 1985. PMID: 2412780 Review. No abstract available.